Tuftsin-derived peptide studied in anxiolytic-signaling models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Tuftsin-derived neuromodulatory research; anxiety-symptom scores and enkephalin-related mechanisms. A small comparative clinical study reported anxiolytic effects, but this does not establish broad cognitive enhancement.
Human evidence cited here is small or exploratory and specific to the studied population and preparation. It does not establish efficacy of the Avitus product.
PMID: 18454096
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.